Lei Doctor Chief Physician

The First Affiliated Hospital, Sun Yat-sen University · Chief Physician

A thoracic surgeon with a Master’s from Sun Yat-sen University (2007), now an Associate Chief Physician at its First Affiliated Hospital. Specializes in esophageal and lung cancer, with research on H2S signaling, chylothorax prevention, and molecular oncology. Holds memberships in Guangdong Medical Association and Cross-Straits Medicine Exchange Association.

Since graduating in 2007, I have been engaged in clinical and scientific research in thoracic surgery. I have extensive experience in the surgical diagnosis and treatment of various common benign and malignant thoracic diseases, including lung cancer, esophageal cancer, mediastinal diseases, pneumothorax, bronchiectasis, pulmonary bullae, and pectus excavatum. I specialize in minimally invasive treatment of thoracic diseases, as well as multidisciplinary comprehensive treatment centered on surge

Lei Doctor
Doctor Photo
Basic Information

About Dr. Lei Doctor

Hospital
The First Affiliated Hospital, Sun Yat-sen University
Title
Chief Physician
Department
Years of Practice
28 years (1998 — present)
**Education and Professional Experience:** 2007: Graduated from Sun Yat-sen University with a Master's degree in Surgery and commenced work at the hospital. 2007-2010: Resident Physician, Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University. 2010-2019: Attending Physician, Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University. 2014-2017: In-service Doctoral Candidate in Surgery, Sun Yat-sen University. 2019-Present: Associate Chief Physician, Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University. **Professional Affiliations:** Member, Cardio-Thoracic Surgery Group, Minimally Invasive Surgery Society, Guangdong Medical Association Member, ERAS Group, Thoracic Surgeons Branch, Guangdong Medical Doctor Association Member, Thoracic Tumor Professional Committee, World Chinese Tumor Physician Association Youth Committee Member, Cross-Straits Medicine Exchange Association Lecturer, Southern China Branch, Thoracic Surgery Academy **Publications:** 1. Lei Y, Xu Q, Zeng B, ZhangW, Zhen Y, Zhai Y, Cheng F, Mei W, Zheng D, Feng J, Lan J, Chen J. Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1/2 pathways, but not the leptin-c-Jun N-terminal kinase pathway in vitro. J Diabetes Investig. 2017 Jul; 8(4): 434-445. 2. Lei Y, Feng Y, Zeng B, Zhang X, Chen J, Zou J, Su C, Liu Z, Luo H, Zhang S. Effect of Prophylactic Thoracic Duct Ligation in Reducing the Incidence of Postoperative Chylothorax during Esophagectomy: A Systematic Review and Meta-analysis. Thorac Cardiovasc Surg. 2017 May 2. 3. Lei Y, Zhen Y, Zhang W, Sun X, Lin X, Feng J, Luo H, Chen Z, Su C, Zeng B, Chen J. Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, angiopoiesis and migration effects via activating HSP90 pathway in EC109 cells. Oncol Rep. 2016 Jun; 35(6): 3714-3720. 4. Lei YY, Liu ZG, Yang WL. Negative correlation of cytoplasm TIMP3 with miR-222 indicates a good prognosis for NSCLC. Onco Targets Ther. 2018; 11: 5551-5557. 5. Lei YY, Feng YF, Zeng B, Zhang W, Xu Q, Cheng F, Lan J, Luo HH, Zou JYong, Chen ZG, Su CH, Zhen YL, Chen JF. Exogenous H2S promotes cancer progress via activating JAK2/STAT3 signaling pathway in EC109 cells. Int J Clin Exp Patho. 2018; 11(7): 3247-3256. 6. Lei YY, Xu YF, Liu ZG. Estrogen receptor beta 2 inhibits growth of lung transplantation tumors in mice by upregulating P38 mitogen-activated protein kinase. Int J Clin Exp Med. 2019;12(5):5598-605. 7. Lu J, Pan Y, Xia X, Gu Y, Lei Y. Prognostic Significance of mTOR and PTEN in Patients with Esophageal Squamous Cell Carcinoma. Biomed Res Int. 2015; 2015: 417210. (Corresponding Author) 8. Zeng B, Zhang X, Zhao JL, Wei ZW, Zhu HS, Fu MY, Zou DW, Feng YF, Luo HH, Lei YY. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma. BMC cancer. 2019 Jun; (19):609. (Corresponding Author) 9. Feng YF, Lei YY, Lu JB, Xi SY, Zhang Y, Huang QT, Wu QL, Wang F. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Cell Death Dis. 2018 Nov; 9(11): 1085. (Co-first Author) 10. Feng Y, Lei Y, Wu X, Huang Y, Rao H, Zhang Y, Wang F. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis. Lung Cancer. 2017 Aug; 110: 48-52. (Co-first Author) 11. Cheang TY, Lei YY, Zhang ZQ, Zhou HY, Ye RY, Lin Y, Wang SM. Graphene oxide-hydroxyapatite nanocomposites effectively deliver HSV-TK suicide gene to inhibit human breast cancer growth. J Biomater Appl. 2018;33(2): 216-226. (Co-first Author) 12. Zeng B, Lei Y, Zhu H, Luo S, Zhuang M, Su C, Zou J, Yang L, Luo H. Aurora-A is a novel predictor of poor prognosis in patients with resected lung adenocarcinoma. Chin J Cancer Res. 2014 Apr; 26(2): 166-173. (Co-first Author) 13. Zhen Y, Wu Q, Ding Y, Zhang W, Zhai Y, Lin X, Weng Y, Guo R, Zhang Y, Feng J, Lei Y, Chen J. Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway. Oncol Lett. 2018 May; 15(5):6562-6570. (Co-corresponding Author) 14. Chen TF, Xie CY, Rao BY, Shan SC, Zhang X, Zeng B, Lei YY, Luo HH. Surgical treatment to multiple primary lung cancer patients: a systematic review and meta-analysis. BMC Surg. 2019; 19: 185. (Co-corresponding Author) 15. Tang YB, Lei YY, Huang S, Li ZY, Chen XT, Luo HH, Cheng C, Chen J, Zou XN, Chen X. Pristimerin exacerbates cellular injury in conditionally reprogrammed patient-derived lung adenocarcinoma cells by aggravating mitochondrial impairment and endoplasmic reticulum stress through EphB4/CDC42/N-WASP signaling. Oxid Med Cell Longev. 2020. (Co-first Author) **Books:** *Surgical Pathophysiology* (Contributing Author) *Perioperative Pathophysiology and Clinical Practice* (Contributing Author)
Schedule

Dr. Lei Doctor — Outpatient Schedule

Weekly clinic, including specialist and surgery days. Book 3-7 days in advance.

Clinic: The First Affiliated Hospital, Sun Yat-sen University · Department
On Duty
Off Duty
Period Morning
08:00-12:00
Afternoon
14:00-17:30
Evening
18:30-20:30
Mon Off Duty Off Duty Off Duty
Tue Off Duty On Duty
14:00 - 17:00
Off Duty
Wed Off Duty Off Duty Off Duty
Thu Off Duty Off Duty Off Duty
Fri Off Duty Off Duty Off Duty
Sat Off Duty Off Duty Off Duty
Sun Off Duty Off Duty Off Duty
Note: Actual clinic hours are subject to the hospital's daily notice. Please call the Dovecure 24h hotline 400-888-0000 to confirm before booking.

Rationale for Precision

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

Book your dedicated advisor now

Senior Medical Advisory Team — With an average of over five years of clinical experience, the team has supported over 1,000 families in accessing coordinated, high-quality medical care in China.

24/7 medical consultation +86 18126771334 (iMessage)
Email Consultation cure@dovecure.com
WeChat dovecure_care
Cart
Your cart is empty
Continue shopping
{{ item.sku_code }} - {{ item.variant_label }} {{ item.item_type_label }}
{{ item.price_format }}
{{ item.subtotal_format }}
Total {{ totalAmount }}
Checkout View Cart
Consult